# Aspire-Lakewood Holdings, Inc.: filings

ASBP · Nasdaq · CIK 1847345 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/asbp.md) · [Financials](/companies/asbp/financials.md) · [Filings](/companies/asbp/filings.md) · [Insiders](/companies/asbp/insiders.md)

## Reports and events: 100 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 59, CORRESP 16, 10-Q 14, 3 14, UPLOAD 14, SCHEDULE 13G/A 13, 425 8, EFFECT 7, S-4/A 7, SC 13G 7, SC 13G/A 7, S-1 6, DEF 14A 5, PRE 14A 5, SCHEDULE 13G 5, 10-K 4, 10-Q/A 4, 4 3, 8-K/A 3, S-1/A 3, DRS/A 2, NT 10-Q 2, S-4 2, 10-K/A 1, 25-NSE 1, 424B3 1, 424B4 1, 4/A 1, 8-A12B 1, CERT 1, DEFA14A 1, DEFR14A 1, DRS 1, DRSLTR 1, NT 10-K 1, RW 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 21:31 ET | [8-K/A](/filings/0001493152-26-047801.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-047801 |
| 2026-09-29 | 21:15 ET | [8-K](/filings/0001493152-26-044908.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-26-044908 |
| 2026-09-09 | 14:10 ET | [8-K](/filings/0001493152-26-041918.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-041918 |
| 2026-09-08 | 14:10 ET | [8-K](/filings/0001493152-26-041725.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-041725 |
| 2026-08-19 | 12:30 ET | [8-K](/filings/0001493152-26-039135.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-039135 |
| 2026-08-13 | 20:31 ET | [10-Q](/filings/0001493152-26-037819.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037819 |
| 2026-08-10 | 13:45 ET | [8-K](/filings/0001493152-26-036777.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036777 |
| 2026-07-20 | 21:20 ET | [8-K](/filings/0001493152-26-033942.md) | 8.01 Other events | 0001493152-26-033942 |
| 2026-06-22 | 20:35 ET | [8-K](/filings/0001493152-26-029599.md) | 5.07 Shareholder vote results | 0001493152-26-029599 |
| 2026-06-12 | 21:15 ET | [8-K](/filings/0001493152-26-028518.md) | 8.01 Other events | 0001493152-26-028518 |
| 2026-06-12 | 14:26 ET | [8-K](/filings/0001493152-26-028386.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028386 |
| 2026-05-15 | 20:16 ET | [10-Q](/filings/0001493152-26-023802.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023802 |
| 2026-05-14 | 20:05 ET | [8-K](/filings/0001493152-26-023069.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-023069 |
| 2026-05-08 | 12:34 ET | [DEF 14A](/filings/0001493152-26-022026.md) | Proxy statement, period 2026-05-08 | 0001493152-26-022026 |
| 2026-04-20 | 13:00 ET | [8-K](/filings/0001493152-26-018018.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-018018 |
| 2026-04-17 | 10:10 ET | [8-K/A](/filings/0001493152-26-017145.md) | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-017145 |
| 2026-04-16 | 21:14 ET | [8-K](/filings/0001493152-26-017115.md) | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-017115 |
| 2026-04-16 | 19:22 ET | [8-K](/filings/0001493152-26-017054.md) | 5.07 Shareholder vote results | 0001493152-26-017054 |
| 2026-04-16 | 12:30 ET | [8-K](/filings/0001493152-26-016979.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-016979 |
| 2026-04-15 | 10:30 ET | [8-K](/filings/0001493152-26-016683.md) | 1.01 Entry into a material agreement | 0001493152-26-016683 |
| 2026-04-10 | 18:54 ET | [S-1/A](/filings/0001493152-26-016123.md) | Registration statement, amended | 0001493152-26-016123 |
| 2026-04-08 | 21:26 ET | [10-K/A](/filings/0001493152-26-015737.md) | Annual report, amended, period 2025-12-31 | 0001493152-26-015737 |
| 2026-03-30 | 21:57 ET | [10-K](/filings/0001493152-26-013682.md) | Annual report, period 2025-12-31 | 0001493152-26-013682 |
| 2026-02-24 | 21:15 ET | [DEF 14A](/filings/0001493152-26-007883.md) | Proxy statement, period 2026-02-24 | 0001493152-26-007883 |
| 2026-02-17 | 21:16 ET | [S-1](/filings/0001493152-26-007123.md) | Registration statement | 0001493152-26-007123 |
| 2026-02-12 | 16:45 ET | [8-K](/filings/0001493152-26-006343.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-006343 |
| 2026-02-06 | 22:25 ET | [8-K](/filings/0001493152-26-005640.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-005640 |
| 2026-01-30 | 22:05 ET | [8-K](/filings/0001493152-26-004543.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-004543 |
| 2026-01-15 | 11:15 ET | [8-K](/filings/0001493152-26-002326.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-002326 |
| 2026-01-13 | 21:30 ET | [8-K](/filings/0001493152-26-002057.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-002057 |
| 2026-01-06 | 13:35 ET | [8-K](/filings/0001493152-26-000518.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-000518 |
| 2025-12-03 | 01:58 ET | [S-1](/filings/0001493152-25-025819.md) | Registration statement | 0001493152-25-025819 |
| 2025-11-14 | 22:01 ET | [10-Q/A](/filings/0001493152-25-023619.md) | Quarterly report, amended, period 2025-09-30 | 0001493152-25-023619 |
| 2025-11-14 | 13:20 ET | [10-Q](/filings/0001493152-25-022595.md) | Quarterly report, period 2025-09-30 | 0001493152-25-022595 |
| 2025-11-14 | 13:00 ET | [8-K](/filings/0001493152-25-022580.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-022580 |
| 2025-11-05 | 21:50 ET | [8-K](/filings/0001493152-25-020891.md) | 5.07 Shareholder vote results | 0001493152-25-020891 |
| 2025-10-17 | 21:15 ET | [8-K](/filings/0001493152-25-018512.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-25-018512 |
| 2025-09-26 | 21:13 ET | [S-1/A](/filings/0001493152-25-015778.md) | Registration statement, amended | 0001493152-25-015778 |
| 2025-09-26 | 21:10 ET | [8-K](/filings/0001493152-25-015773.md) | 3.02 Unregistered sale of equity; 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-25-015773 |
| 2025-09-23 | 23:08 ET | [DEF 14A](/filings/0001493152-25-014523.md) | Proxy statement, period 2025-09-22 | 0001493152-25-014523 |
| 2025-09-18 | 20:56 ET | [S-1](/filings/0001493152-25-014085.md) | Registration statement | 0001493152-25-014085 |
| 2025-08-22 | 21:15 ET | [8-K](/filings/0001641172-25-025257.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-025257 |
| 2025-08-13 | 21:02 ET | [10-Q](/filings/0001641172-25-023573.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023573 |
| 2025-08-13 | 21:01 ET | [10-Q/A](/filings/0001641172-25-023566.md) | Quarterly report, amended, period 2025-03-31 | 0001641172-25-023566 |
| 2025-07-30 | 21:29 ET | [8-K](/filings/0001641172-25-021595.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-021595 |
| 2025-06-18 | 21:29 ET | [8-K](/filings/0001641172-25-015653.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-015653 |
| 2025-06-10 | 12:30 ET | [8-K](/filings/0001641172-25-014445.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-014445 |
| 2025-05-14 | 20:45 ET | [10-Q](/filings/0001641172-25-010316.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010316 |
| 2025-05-13 | 21:21 ET | [S-1](/filings/0001641172-25-010013.md) | Registration statement | 0001641172-25-010013 |
| 2025-04-30 | 20:57 ET | [8-K](/filings/0001641172-25-007852.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-007852 |

Page 1 of 2. [Older](/companies/asbp/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.